U2Bio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2014	FY 2013
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Cash & Equivalents	3,275	16,489	35,290	1,433	906.21	198.09
Short-Term Investments	-	16,500	-	34,000	100	25
Trading Asset Securities	30,404	1,001	1,501	1,489	-	-
Cash & Short-Term Investments	33,679	33,991	36,792	36,921	1,006	223.09
Cash Growth	-2.19%	-7.61%	-0.35%	3569.37%	351.03%	-
Accounts Receivable	7,320	6,944	7,300	9,935	9,328	7,302
Other Receivables	380.75	532.39	90.76	247.23	23.04	17.79
Receivables	7,742	7,477	7,391	10,183	9,436	7,434
Inventory	740.9	727.58	782.8	695.58	393.94	498.38
Prepaid Expenses	5.77	129.73	205.52	2.52	-	-
Other Current Assets	124.6	7.4	0.62	71.15	0.78	0.33
Total Current Assets	42,292	42,332	45,172	47,873	10,837	8,156
Property, Plant & Equipment	830.51	1,186	1,549	1,871	585.01	315.34
Long-Term Investments	0	-0	0	-0	109.85	109.85
Other Intangible Assets	1,057	363.74	364.62	172.87	-	5.99
Long-Term Deferred Tax Assets	-	-	1,281	615.14	-	-
Long-Term Deferred Charges	-	656.76	365.31	-	213.93	-
Other Long-Term Assets	458.88	444.73	466.95	496.41	148.22	113.96
Total Assets	44,710	44,983	49,199	51,028	11,959	8,712
Accounts Payable	2,565	2,730	3,711	4,656	1,610	1,554
Accrued Expenses	936.43	994.14	961.87	3,445	75.43	68.39
Short-Term Debt	-	-	-	-	804	869
Current Portion of Long-Term Debt	-	-	-	-	1,793	1,154
Current Portion of Leases	132.88	285.83	260.31	416.95	-	-
Current Income Taxes Payable	-	-	-	2,662	-	-
Other Current Liabilities	2,785	2,603	3,070	3,454	1,494	1,338
Total Current Liabilities	6,420	6,614	8,003	14,634	5,776	4,983
Long-Term Debt	-	-	-	-	1,782	1,649
Long-Term Leases	133.85	172.23	191.96	104.64	-	-
Other Long-Term Liabilities	40.53	44.11	30.05	52.88	195.97	-
Total Liabilities	10,418	10,555	11,208	17,184	8,080	7,123
Common Stock	5,644	5,644	5,644	1,263	723.33	590
Additional Paid-In Capital	13,935	13,935	13,935	13,426	2,884	2,483
Retained Earnings	14,722	14,858	18,422	19,164	271.68	-1,483
Comprehensive Income & Other	-8.66	-8.66	-8.66	-8.66	-	-
Shareholders' Equity	34,292	34,427	37,991	33,844	3,879	1,590
Total Liabilities & Equity	44,710	44,983	49,199	51,028	11,959	8,712
Total Debt	266.73	458.06	452.27	521.59	4,379	3,672
Net Cash (Debt)	33,412	33,533	36,340	36,400	-3,373	-3,449
Net Cash Growth	-2.24%	-7.72%	-0.17%	-	-	-
Net Cash Per Share	2943.69	2970.85	3544.53	3604.03	-2333.98	-2925.50
Filing Date Shares Outstanding	11.29	11.29	11.29	10.1	1.45	1.18
Total Common Shares Outstanding	11.29	11.29	11.29	10.1	1.45	1.18
Working Capital	35,872	35,718	37,169	33,239	5,061	3,173
Book Value Per Share	3038.11	3050.13	3365.89	3350.98	2684.51	1348.28
Tangible Book Value	33,235	34,064	37,627	33,671	3,879	1,584
Tangible Book Value Per Share	2944.50	3017.91	3333.58	3333.87	2684.51	1343.20
Machinery	-	2,382	2,331	3,821	1,438	942.53

Source: S&P Global Market Intelligence. Standard template. Financial Sources.